Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Pecs Block in Breast Cancer Surgery
NCT04327063Phase 3Completed
- Sponsor
- Institut Curie
- Start
- Aug 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in breast cancer, sponsored by Institut Curie. Started Aug 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04327063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04327063.